Metropolitan Life Insurance Company (MetLife)’s Abeona Therapeutics ABEO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-398	Closed	-$47.6K	–	2572
2019 Q2	$47.6K	Hold	398	–	–	﹤0.01%	2509
2019 Q1	$73.3K	Sell	398 -10	-2%	-$1.79K	﹤0.01%	2470
2018 Q4	$72.8K	Hold	408	–	–	﹤0.01%	2468
2018 Q3	$130K	Hold	408	–	–	﹤0.01%	2291
2018 Q2	$163K	Buy	408 +44	+12%	+$19.2K	﹤0.01%	2069
2018 Q1	$131K	Hold	364	–	–	﹤0.01%	2155
2017 Q4	$144K	Sell	364 -343	-49%	-$142K	﹤0.01%	2102
2017 Q3	$301K	Buy	+707	New	+$190K	﹤0.01%	2031

Other funds holding ABEO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ABEO Position: Q3 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Abeona Therapeutics (ABEO) in Q3 2019, closing a stake of 398 shares — an estimated $47.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ABEO in Q3 2017 and held it in 8 quarters. The position peaked at $301K in Q3 2017. 79 funds tracked by Wall St. Rank hold ABEO as of Q3 2019.

Metropolitan Life Insurance Company (MetLife) reported no remaining Abeona Therapeutics position as of Q3 2019 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 398 Abeona Therapeutics shares in Q3 2019, an estimated $47.6K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Abeona Therapeutics in Q3 2017 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Abeona Therapeutics position peaked at $301K in Q3 2017.
79 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2019, filed 14 Nov 2019.